TY - JOUR
T1 - The effect of cellular isolation and cryopreservation on the expression of markers identifying subsets of regulatory T cells
AU - Zhang, Weiying
AU - Nilles, Tricia L.
AU - Johnson, Jacquett R.
AU - Margolick, Joseph B.
N1 - Funding Information:
We thank Paula Mercado and Ginnie Khoza for the isolation and cryopreservation of PBMC; the Baltimore–Washington, DC site of the MACS: the Study to Help the AIDS Research Effort (SHARE) office and clinic staff for the conduct of the SHARE study; and SHARE participants for their long-term participation in the SHARE study. This work was supported by the National Institutes of Health ( U01 AI35042 ).
Publisher Copyright:
© 2016 Elsevier B.V.
PY - 2016/4/1
Y1 - 2016/4/1
N2 - Background: The role of CD4+ regulatory T cells (Tregs) and their subsets during HIV infection is controversial. Cryopreserved peripheral blood mononuclear cells (PBMC) are an important source for assessing number and function of Tregs. However, it is unknown if PBMC isolation and cryopreservation affect the expression of CD120b and CD39, markers that identify specific subsets of Tregs. Methods: HIV-uninfected (HIV-) and -infected (HIV+) men were randomly selected from the Multicenter AIDS Cohort Study (MACS). Percentages of CD120b+ and CD39+ Tregs measured by flow cytometry in whole blood and in corresponding fresh and cryopreserved PBMC were compared. Results: Percentages of CD120b+ Tregs were significantly lower in a) fresh PBMC relative to whole blood, and b) freshly thawed frozen PBMC relative to fresh PBMC when the recovery of viable cryopreserved cells was low. When present, low expression of CD120b in frozen PBMC was reversible by 4 h of in vitro culture. In contrast, expression of CD39 on Tregs was not affected by isolation and/or cryopreservation of PBMC, or by relative recovery of cryopreserved PBMC. These findings were unaffected by the HIV status of the donor. Conclusion: The data suggest that percentages of CD120b+ Tregs and CD39+ Tregs can be validly measured in either whole blood or PBMC (fresh and frozen) in HIV- and HIV+ men. However, for measurement of CD120b+ Tregs one type of sample should be used consistently within a given study, and thawed frozen cells may require in vitro culture if recovery of viable cells is low.
AB - Background: The role of CD4+ regulatory T cells (Tregs) and their subsets during HIV infection is controversial. Cryopreserved peripheral blood mononuclear cells (PBMC) are an important source for assessing number and function of Tregs. However, it is unknown if PBMC isolation and cryopreservation affect the expression of CD120b and CD39, markers that identify specific subsets of Tregs. Methods: HIV-uninfected (HIV-) and -infected (HIV+) men were randomly selected from the Multicenter AIDS Cohort Study (MACS). Percentages of CD120b+ and CD39+ Tregs measured by flow cytometry in whole blood and in corresponding fresh and cryopreserved PBMC were compared. Results: Percentages of CD120b+ Tregs were significantly lower in a) fresh PBMC relative to whole blood, and b) freshly thawed frozen PBMC relative to fresh PBMC when the recovery of viable cryopreserved cells was low. When present, low expression of CD120b in frozen PBMC was reversible by 4 h of in vitro culture. In contrast, expression of CD39 on Tregs was not affected by isolation and/or cryopreservation of PBMC, or by relative recovery of cryopreserved PBMC. These findings were unaffected by the HIV status of the donor. Conclusion: The data suggest that percentages of CD120b+ Tregs and CD39+ Tregs can be validly measured in either whole blood or PBMC (fresh and frozen) in HIV- and HIV+ men. However, for measurement of CD120b+ Tregs one type of sample should be used consistently within a given study, and thawed frozen cells may require in vitro culture if recovery of viable cells is low.
KW - CD120b
KW - CD39
KW - CD4 regulatory T cells
KW - HIV
KW - PBMC cryopreservation
UR - http://www.scopus.com/inward/record.url?scp=84960268047&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84960268047&partnerID=8YFLogxK
U2 - 10.1016/j.jim.2016.02.004
DO - 10.1016/j.jim.2016.02.004
M3 - Article
C2 - 26855370
AN - SCOPUS:84960268047
SN - 0022-1759
VL - 431
SP - 31
EP - 37
JO - Journal of Immunological Methods
JF - Journal of Immunological Methods
ER -